CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Surexam Bio-Tech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Surexam Bio-Tech Co Ltd
5F, BLK B/C, Gngzhu Tchnlgy Invtn base
No.80 Lanyue Road, Science City
Phone: +86 2032290198p:+86 2032290198 GUANGZHOU, GNG  510663  China Fax: +86 2032057122f:+86 2032057122
Business Summary
SurExam Bio-Tech Co., Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of medical testing products. The Company also provides related testing services. The Company mainly operates its business in domestic market.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201112/31/2011Yes----

Industries
SIC Code Description
8071 Medical laboratories
3841 Surgical and medical instruments and apparatus

General Information
Outstanding Shares: 50,000,000 (As of 12/31/2013)
Fax Number: +86 2032057122


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, October 26, 2023